Piyush Jain is a Pharmacovigilance Assessor at famhp, currently assessing safety reports for COVID-19 vaccines. Previously, Piyush worked as a Postdoctoral Research Fellow at Research Foundation Flanders and KU Leuven, focusing on the role of mast cells in Irritable Bowel Syndrome and Human enteric nerve tissue culture. Piyush also conducted research on TRPA1 channels in colitis at the University of Florence and psychopharmacology of visceral pain at the Medical University of Graz. Piyush has a Ph.D. in Neuroscience, a Master's in Pharmacy, and a Bachelor's degree in Pharmacy.
FAMHP - Federal Agency for Medicines and Health Products
The Federal Agency for Medicines and Health Products (FAMHP) is the Belgian competent authority in charge of ensuring the quality, safety and efficacy of medicines and health products (medical devices and accessories, raw materials, blood and blood products of human origin, human tissue material), for human and veterinary use, in clinical development and on the market. The famhp works together with the academic world, the pharmaceutical industry and the other industries concerned, healthcare professionals, other national, European and worldwide authorities, as well as policy makers, in order to provide everybody with the necessary medicines and health products and to help patients and citizens to use them correctly. The famhp has grown since its creation from an organization with a few dozen employees to an agency that has more than 500 employees which are mostly scientifically trained. The agency consists out of five entities: three Directorates-General, DG PRE authorisation, DG POST authorisation and DG INSPECTION, the support services and the CEO Services.